Published in J Clin Microbiol on October 01, 1997
Ehrlichia chaffeensis: a prototypical emerging pathogen. Clin Microbiol Rev (2003) 3.39
Sequential evaluation of dogs naturally infected with Ehrlichia canis, Ehrlichia chaffeensis, Ehrlichia equi, Ehrlichia ewingii, or Bartonella vinsonii. J Clin Microbiol (1998) 2.48
Human ehrlichiosis and anaplasmosis. Clin Lab Med (2010) 2.00
New Ehrlichia species closely related to Ehrlichia chaffeensis isolated from Ixodes ovatus ticks in Japan. J Clin Microbiol (2000) 1.64
Human granulocytic ehrlichiosis agent and Ehrlichia chaffeensis reside in different cytoplasmic compartments in HL-60 cells. Infect Immun (1999) 1.59
Molecular cloning and characterization of the Ehrlichia chaffeensis variable-length PCR target: an antigen-expressing gene that exhibits interstrain variation. J Clin Microbiol (1999) 1.51
Ehrlichia chaffeensis expresses macrophage- and tick cell-specific 28-kilodalton outer membrane proteins. Infect Immun (2005) 1.32
Genetic diversity of the 28-kilodalton outer membrane protein gene in human isolates of Ehrlichia chaffeensis. J Clin Microbiol (1999) 1.29
Persistent Ehrlichia chaffeensis infection occurs in the absence of functional major histocompatibility complex class II genes. Infect Immun (2002) 1.27
Surface-exposed proteins of Ehrlichia chaffeensis. Infect Immun (2007) 1.26
Ehrlichia chaffeensis and E. sennetsu, but not the human granulocytic ehrlichiosis agent, colocalize with transferrin receptor and up-regulate transferrin receptor mRNA by activating iron-responsive protein 1. Infect Immun (1999) 1.20
Antigenic variation of Ehrlichia chaffeensis resulting from differential expression of the 28-kilodalton protein gene family. Infect Immun (2002) 1.10
Molecular heterogeneity of Ehrlichia chaffeensis isolates determined by sequence analysis of the 28-kilodalton outer membrane protein genes and other regions of the genome. Infect Immun (2003) 1.09
Western and dot blotting analyses of Ehrlichia chaffeensis indirect fluorescent-antibody assay-positive and -negative human sera by using native and recombinant E. chaffeensis and E. canis antigens. J Clin Microbiol (1999) 1.09
Comparison of Ehrlichia chaffeensis recombinant proteins for serologic diagnosis of human monocytotropic ehrlichiosis. J Clin Microbiol (1999) 1.08
Proteomic analysis of and immune responses to Ehrlichia chaffeensis lipoproteins. Infect Immun (2008) 1.07
Quantitative real-time PCR assay for detection of Ehrlichia chaffeensis. J Clin Microbiol (2003) 1.07
Outcome of diagnostic tests using samples from patients with culture-proven human monocytic ehrlichiosis: implications for surveillance. J Clin Microbiol (1999) 1.06
PCR amplification and phylogenetic analysis of groESL operon sequences from Ehrlichia ewingii and Ehrlichia muris. J Clin Microbiol (2000) 1.02
Virulence potential of Ehrlichia chaffeensis strains of distinct genome sequences. Infect Immun (2007) 1.02
Lyme borreliosis in human patients in Florida and Georgia, USA. Int J Med Sci (2013) 1.00
Diagnosis of human ehrlichiosis by PCR assay of acute-phase serum. J Clin Microbiol (1999) 0.98
Severe Ehrlichia chaffeensis infection in a lung transplant recipient: a review of ehrlichiosis in the immunocompromised patient. Emerg Infect Dis (2002) 0.93
Delayed clearance of Ehrlichia chaffeensis infection in CD4+ T-cell knockout mice. Infect Immun (2004) 0.93
Genetic and antigenic diversities of major immunoreactive proteins in globally distributed Ehrlichia canis strains. Clin Vaccine Immunol (2008) 0.90
Molecular variation in the variable-length PCR target and 120-kilodalton antigen genes of Ehrlichia chaffeensis from white-tailed deer (Odocoileus virginianus). J Clin Microbiol (2003) 0.89
An animal model of a newly emerging human ehrlichiosis. J Infect Dis (2014) 0.88
Transmission electron microscopy reveals distinct macrophage- and tick cell-specific morphological stages of Ehrlichia chaffeensis. PLoS One (2012) 0.88
Ehrlichia chaffeensis infection in the reservoir host (white-tailed deer) and in an incidental host (dog) is impacted by its prior growth in macrophage and tick cell environments. PLoS One (2014) 0.87
Defining the immune response to Ehrlichia species using murine models. Vet Parasitol (2008) 0.86
Molecular characterization of Ehrlichia interactions with tick cells and macrophages. Front Biosci (Landmark Ed) (2009) 0.85
Progress and obstacles in vaccine development for the ehrlichioses. Expert Rev Vaccines (2010) 0.84
Ehrlichia chaffeensis infection of sika deer, Japan. Emerg Infect Dis (2009) 0.84
First reported case of Ehrlichia ewingii involving human bone marrow. J Clin Microbiol (2014) 0.83
In vitro isolation and molecular characterization of an Ehrlichia canis strain from São Paulo, Brazil. Braz J Microbiol (2008) 0.82
Ehrlichia chaffeensis uses its surface protein EtpE to bind GPI-anchored protein DNase X and trigger entry into mammalian cells. PLoS Pathog (2013) 0.81
Ehrlichia moonlighting effectors and interkingdom interactions with the mononuclear phagocyte. Microbes Infect (2013) 0.80
Hacker within! Ehrlichia chaffeensis Effector Driven Phagocyte Reprogramming Strategy. Front Cell Infect Microbiol (2016) 0.78
Bacterial Profiling Reveals Novel "Ca. Neoehrlichia", Ehrlichia, and Anaplasma Species in Australian Human-Biting Ticks. PLoS One (2015) 0.78
Molecular detection of Ehrlichia chaffeensis in humans, Costa Rica. Emerg Infect Dis (2015) 0.78
Comparative Experimental Infection Study in Dogs with Ehrlichia canis, E. chaffeensis, Anaplasma platys and A. phagocytophilum. PLoS One (2016) 0.77
Ehrlichia chaffeensis TRP120 Activates Canonical Notch Signaling To Downregulate TLR2/4 Expression and Promote Intracellular Survival. MBio (2016) 0.77
Comparative Genomics of the Zoonotic Pathogen Ehrlichia chaffeensis Reveals Candidate Type IV Effectors and Putative Host Cell Targets. Front Cell Infect Microbiol (2017) 0.75
Ehrlichia chaffeensis, a new species associated with human ehrlichiosis. J Clin Microbiol (1991) 8.36
Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? JAMA (1994) 6.55
Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis. J Clin Microbiol (1991) 6.00
Emergence of the ehrlichioses as human health problems. Emerg Infect Dis (1996) 3.89
Detection of the etiologic agent of human ehrlichiosis by polymerase chain reaction. J Clin Microbiol (1992) 3.81
Ultrastructural variation of cultured Ehrlichia chaffeensis. J Med Microbiol (1995) 2.78
Ehrlichiosis presenting as a life-threatening illness with features of the toxic shock syndrome. Am J Med (1993) 2.67
Epidemiologic, clinical, and laboratory findings of human ehrlichiosis in the United States, 1988. JAMA (1990) 2.60
PCR amplification and comparison of nucleotide sequences from the groESL heat shock operon of Ehrlichia species. J Clin Microbiol (1997) 2.59
Ultrastructural and antigenic characterization of a granulocytic ehrlichiosis agent directly isolated and stably cultivated from a patient in New York state. J Infect Dis (1997) 2.26
Reisolation of Ehrlichia canis from blood and tissues of dogs after doxycycline treatment. J Clin Microbiol (1994) 1.88
Cloning and sequencing of the gene for a 120-kDa immunodominant protein of Ehrlichia chaffeensis. Gene (1997) 1.86
A macrophage-monocyte cell line from a dog with malignant histiocytosis. In Vitro Cell Dev Biol (1988) 1.70
Abrogation of gamma interferon-induced inhibition of Ehrlichia chaffeensis infection in human monocytes with iron-transferrin. Infect Immun (1994) 1.68
Isolation of Ehrlichia chaffeensis from wild white-tailed deer (Odocoileus virginianus) confirms their role as natural reservoir hosts. J Clin Microbiol (1997) 1.67
Ehrlichia chaffeensis expresses an immunoreactive protein homologous to the Escherichia coli GroEL protein. Infect Immun (1993) 1.62
An outbreak of ehrlichiosis in members of an Army Reserve unit exposed to ticks. J Infect Dis (1989) 1.55
Isolation and characterization of a new strain of Ehrlichia chaffeensis from a patient with nearly fatal monocytic ehrlichiosis. J Clin Microbiol (1995) 1.54
Brief report: fatal seronegative ehrlichiosis in a patient with HIV infection. N Engl J Med (1993) 1.32
Seroepidemiology of infections due to spotted fever group rickettsiae and Ehrlichia species in military personnel exposed in areas of the United States where such infections are endemic. J Infect Dis (1995) 1.21
Human ehrlichiosis. Mo Med (1989) 1.20
Genetic and antigenic diversity of Ehrlichia chaffeensis: comparative analysis of a novel human strain from Oklahoma and previously isolated strains. J Infect Dis (1997) 1.20
Comparative antigenic analysis of spotted fever group rickettsiae from Israel and other closely related organisms. Am J Trop Med Hyg (1995) 1.12
Cultivation of Ehrlichia chaffeensis in mouse embryo, Vero, BGM, and L929 cells and study of Ehrlichia-induced cytopathic effect and plaque formation. Infect Immun (1995) 1.11
Comparison of the rompA gene repeat regions of Rickettsiae reveals species-specific arrangements of individual repeating units. Gene (1993) 1.06
Human endothelial cells as an alternative to DH82 cells for isolation of Ehrlichia chaffeensis, E. canis, and Rickettsia rickettsii. Pathobiology (1993) 0.96
Cytopathic effect, plaque formation, and lysis of Ehrlichia chaffeensis grown on continuous cell lines. Infect Immun (1994) 0.95
Human ehrlichiosis in a liver transplant recipient. Transplantation (1995) 0.92
Pneumonia, aseptic meningitis, and leukopenia in a 28-year-old man. Clin Infect Dis (1993) 0.82
All ras proteins are polyisoprenylated but only some are palmitoylated. Cell (1989) 9.68
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Isolation of Legionella spp. from environmental water samples by low-pH treatment and use of a selective medium. J Clin Microbiol (1981) 6.88
Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis. J Clin Microbiol (1991) 6.00
Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol (1995) 5.30
Nanomaterials: a membrane-based synthetic approach. Science (1994) 4.60
Detection of the etiologic agent of human ehrlichiosis by polymerase chain reaction. J Clin Microbiol (1992) 3.81
A western gray whale mitigation and monitoring program for a 3-D seismic survey, Sakhalin Island, Russia. Environ Monit Assess (2007) 3.62
Patterns of association with host and habitat: antibody reactive with Sin Nombre virus in small mammals in the major biotic communities of the southwestern United States. Am J Trop Med Hyg (1997) 3.46
Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N Engl J Med (1999) 3.45
A case-control study of hantavirus pulmonary syndrome during an outbreak in the southwestern United States. J Infect Dis (1995) 2.95
Amblyomma americanum: a potential vector of human ehrlichiosis. Am J Trop Med Hyg (1993) 2.84
Distribution, diversity, and host specificity of Bartonella in rodents from the Southeastern United States. Am J Trop Med Hyg (1997) 2.77
The ascension of wildlife rabies: a cause for public health concern or intervention? Emerg Infect Dis (1996) 2.45
Susceptibility of white-tailed deer (Odocoileus virginianus) to infection with Ehrlichia chaffeensis, the etiologic agent of human ehrlichiosis. J Clin Microbiol (1994) 2.44
Association of intraspecific wounding with hantaviral infection in wild rats (Rattus norvegicus). Epidemiol Infect (1988) 2.37
Long-term studies of hantavirus reservoir populations in the southwestern United States: a synthesis. Emerg Infect Dis (1999) 2.36
Ecologic studies of rodent reservoirs: their relevance for human health. Emerg Infect Dis (1999) 2.32
An indirect immunofluorescence assay using a cell culture-derived antigen for detection of antibodies to the agent of human granulocytic ehrlichiosis. J Clin Microbiol (1997) 2.32
A reassortant bunyavirus isolated from acute hemorrhagic fever cases in Kenya and Somalia. Virology (2001) 2.28
The human ehrlichioses in the United States. Emerg Infect Dis (1999) 2.22
Use of Bartonella antigens for serologic diagnosis of cat-scratch disease at a national referral center. Arch Intern Med (1995) 2.15
Isolation of the causative agent of hantavirus pulmonary syndrome. Am J Trop Med Hyg (1994) 2.07
Hidden mortality attributable to Rocky Mountain spotted fever: immunohistochemical detection of fatal, serologically unconfirmed disease. J Infect Dis (1999) 2.05
Rats of the genus Rattus are reservoir hosts for pathogenic Bartonella species: an Old World origin for a New World disease? J Infect Dis (1999) 2.03
A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 1.96
Epidemiology of human rabies in the United States, 1980 to 1996. Ann Intern Med (1998) 1.95
A longitudinal study of Junin virus activity in the rodent reservoir of Argentine hemorrhagic fever. Am J Trop Med Hyg (1992) 1.86
Pathogenic potential of filoviruses: role of geographic origin of primate host and virus strain. J Infect Dis (1992) 1.84
Appropriateness of rabies postexposure prophylaxis treatment for animal exposures. Emergency ID Net Study Group. JAMA (2000) 1.83
Pathologic features of filovirus infections in humans. Curr Top Microbiol Immunol (1999) 1.83
Antigenic characteristics of isolates associated with a new epizootic of raccoon rabies in the United States. J Infect Dis (1984) 1.72
National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg (1995) 1.72
Ehrlichiosis in a golf-oriented retirement community. N Engl J Med (1995) 1.71
Prevalence of antibody to hepatitis E virus among rodents in the United States. J Infect Dis (2000) 1.70
Search for the Ebola virus reservoir in Kikwit, Democratic Republic of the Congo: reflections on a vertebrate collection. J Infect Dis (1999) 1.70
PCR detection of granulocytic ehrlichiae in Ixodes ricinus ticks and wild small mammals in western Switzerland. J Clin Microbiol (2000) 1.68
Rabies surveillance in the United States during 1993. J Am Vet Med Assoc (1994) 1.67
Prediction of relapse after treatment of coccidioidomycosis. Clin Infect Dis (1997) 1.58
Serologic testing for human granulocytic ehrlichiosis at a national referral center. J Clin Microbiol (1999) 1.58
White-tailed deer as a potential reservoir of Ehrlichia spp. J Wildl Dis (1994) 1.53
Molecular cloning and characterization of the Ehrlichia chaffeensis variable-length PCR target: an antigen-expressing gene that exhibits interstrain variation. J Clin Microbiol (1999) 1.51
Hantavirus (Bunyaviridae) infections in rodents from Orange and San Diego counties, California. Am J Trop Med Hyg (1999) 1.51
Human granulocytic ehrlichiosis in Europe: clinical and laboratory findings for four patients from Slovenia. Clin Infect Dis (1998) 1.50
Assessing the role of long-distance translocation and spatial heterogeneity in the raccoon rabies epidemic in Connecticut. Prev Vet Med (2005) 1.50
Metal nanotubule membranes with electrochemically switchable ion-transport selectivity. Science (1995) 1.50
Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus. Clin Infect Dis (2001) 1.49
Small mammal survival and trapability in mark-recapture monitoring programs for hantavirus. J Wildl Dis (1998) 1.49
Experimental evaluation of rodent exclusion methods to reduce hantavirus transmission to humans in rural housing. Am J Trop Med Hyg (1997) 1.47
A survey of hantavirus antibody in small-mammal populations in selected United States National Parks. Am J Trop Med Hyg (1998) 1.47
Evaluation of intraspecies genetic variation within the 60 kDa heat-shock protein gene (groEL) of Bartonella species. Int J Syst Bacteriol (1999) 1.47
Identity of ehrlichial DNA sequences derived from Ixodes ricinus ticks with those obtained from patients with human granulocytic ehrlichiosis in Slovenia. J Clin Microbiol (1999) 1.47
Intradermal use of human diploid cell vaccine for preexposure rabies immunizations. J Am Vet Med Assoc (1982) 1.45
Genes and schizophrenia: a pseudoscientific disenfranchisement of the individual. J Psychiatr Ment Health Nurs (2011) 1.40
Induction of human herpesvirus-8 DNA replication and transcription by butyrate and TPA in BCBL-1 cells. J Gen Virol (1999) 1.37
An outbreak of acute bartonellosis (Oroya fever) in the Urubamba region of Peru, 1998. Am J Trop Med Hyg (1999) 1.37
Epizootiology of Hantavirus infections in Baltimore: isolation of a virus from Norway rats, and characteristics of infected rat populations. Am J Epidemiol (1987) 1.33
Studies on human immunodeficiency virus-induced cytopathic effects: use of human rhabdomyosarcoma (RD) cells. Arch Virol (1988) 1.33
Serologic evidence of infection with Ehrlichia spp. in wild rodents (Muridae: Sigmodontinae) in the United States. J Clin Microbiol (1998) 1.32
Causes, costs, and estimates of rabies postexposure prophylaxis treatments in the United States. J Public Health Manag Pract (1998) 1.32
Spatiotemporal analysis of epizootic raccoon rabies propagation in Connecticut, 1991-1995. Vector Borne Zoonotic Dis (2002) 1.30
Transmission of tick-borne agents of disease by blood transfusion: a review of known and potential risks in the United States. Transfusion (2000) 1.29
Current issues in rabies prevention in the United States health dilemmas. Public coffers, private interests. Public Health Rep (1996) 1.29
Rabies surveillance in the United States during 1994. J Am Vet Med Assoc (1995) 1.29
Mass human exposure to rabies in New Hampshire: exposures, treatment, and cost. Am J Public Health (1996) 1.28
Long-term studies of hantavirus reservoir populations in the southwestern United States: rationale, potential, and methods. Emerg Infect Dis (1999) 1.28
Serologic and molecular detection of granulocytic ehrlichiosis in Rhode Island. J Clin Microbiol (1997) 1.26
Global survey of antibody to Hantaan-related viruses among peridomestic rodents. Bull World Health Organ (1986) 1.25
Dusky-footed wood rats (Neotoma fuscipes) as reservoirs of granulocytic Ehrlichiae (Rickettsiales: Ehrlichieae) in northern California. J Clin Microbiol (1999) 1.25
Analysis of risk factors for fatal Rocky Mountain Spotted Fever: evidence for superiority of tetracyclines for therapy. J Infect Dis (2001) 1.25
Antibodies to Bartonella species in inner-city intravenous drug users in Baltimore, Md. Arch Intern Med (1996) 1.24
Evidence of rodent-associated Bartonella and Rickettsia infections among intravenous drug users from Central and East Harlem, New York City. Am J Trop Med Hyg (2001) 1.24
Growth properties of human herpesvirus-6 strain Z29. J Virol Methods (1989) 1.23
Domestic cases of hemorrhagic fever with renal syndrome in the United States. Nephron (1994) 1.23
Infection with a ratborne hantavirus in US residents is consistently associated with hypertensive renal disease. J Infect Dis (1993) 1.22
Anti-tick saliva antibody: a biologic marker of tick exposure that is a risk factor for Lyme disease seropositivity. Am J Epidemiol (1991) 1.22
Primary isolation of Ehrlichia chaffeensis from patients with febrile illnesses: clinical and molecular characteristics. J Infect Dis (2000) 1.22
Evaluation of a canine rabies vaccination campaign and characterization of owned-dog populations in the Philippines. Southeast Asian J Trop Med Public Health (1996) 1.22
Asymmetric diffusion through synthetic nanopores. Phys Rev Lett (2005) 1.19
Electroosmotic flow in template-prepared carbon nanotube membranes. J Am Chem Soc (2001) 1.19
Life-threatening Cache Valley virus infection. N Engl J Med (1997) 1.19
Urban zoonoses caused by Bartonella, Coxiella, Ehrlichia, and Rickettsia species. Vector Borne Zoonotic Dis (2001) 1.19
Sin Nombre virus glycoprotein trafficking. Virology (2003) 1.17
Serum gamma-glutamyl transpeptidase activity in viral hepatitis: suppression in pregnancy and by birth control pills. Gastroenterology (1977) 1.17
Rocky Mountain spotted fever in the United States, 1993-1996. Am J Trop Med Hyg (2001) 1.17
Antibody response to preexposure human diploid-cell rabies vaccine given concurrently with chloroquine. N Engl J Med (1986) 1.16
The Hantaviruses, etiologic agents of hemorrhagic fever with renal syndrome: a possible cause of hypertension and chronic renal disease in the United States. Annu Rev Public Health (1992) 1.14
Black Creek Canal Virus infection in Sigmodon hispidus in southern Florida. Am J Trop Med Hyg (1998) 1.12
Rabies surveillance in the United States during 1998. J Am Vet Med Assoc (1999) 1.11
Isolation of Bartonella spp. from embryos and neonates of naturally infected rodents. J Wildl Dis (1998) 1.10
Prevalence of antibodies to arenaviruses in rodents from the southern and western United States: evidence for an arenavirus associated with the genus Neotoma. Am J Trop Med Hyg (1996) 1.09
Mutation in the primer binding site of the type 1 human immunodeficiency virus genome affects virus production and infectivity. Proc Natl Acad Sci U S A (1992) 1.09
Further analyses of the orthopoxviruses volepox virus and raccoon poxvirus. Virology (1992) 1.09